Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) clearance from the FDA for its TriLEAP Lower Extremity Anatomic Plating System, a comprehensive yet modular, procedure-specific system designed to meet the complex needs of orthopaedic surgeons, doctors of podiatric medicine, and foot and ankle specialists.
Boots Dual Action Athlete's Foot Cream is indicated for the treatment and prevention of Athlete's Foot (Tinea Pedis). It is also effective in other conditions, such as Dhobie Itch (Tinea Cruris).
Treatment of athlete's foot. The preparation is not for vaginal use.
Canesten Hydrocortisone is indicated for the treatment of the following skin infections where co-existing symptoms of inflammation, e.g. itching, require rapid relief: (i) Athlete's foot. (ii) Candidal intertrigo.
The treatment of tinea pedis (athlete's foot) caused by Trichophyton (e.g. T . rubrum , T . mentagrophytes , T . verrucosum , T . violaceum ) and Epidermophyton floccosum .
The product is indicated for the adjunctive treatment and prevention of athlete's foot ( tinea pedis). It may also be helpful in conditions where tenderness and sweating cause skin irritation. It is also effective in other conditions, such as dhobie itch ( tinea cruris) and prickly heat (miliaria).
Introduction: Coagulopathic bleeding is a serious complication of cardiac surgery to which an important contributor is acquired hypofibrinogenaemia (plasma fibrinogen <1.5-2.0 g/L).
Objectives: To determine, in a European cohort, the prevalence and health-related quality-of-life (QOL) burden of moderate-to-severe vasomotor symptoms (VMS) in postmenopausal women, and among subgroups of women not taking hormone therapy (HT).
For the treatment of tinea pedis and tinea cruris.
Merck Inc., known as MSD outside of the United States and Canada, announced positive data from multiple Phase II studies evaluating V 116, the company’s investigational, adult-specific 21-valent pneumococcal conjugate vaccine, at the 13th Meeting of the International Society of Pneumonia and Pneumococcal Diseases (ISPPD) in Cape Town, South Africa